Aarti Mittal, DO
Pulmonary Disease · Moreno Valley, CANPI 1194035691
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $34,450 of the $53,172 with a category attached, or 64.8%. Stryker accounts for 72.0% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $38,656, more than ten times the $407 reported in 2022. Among pulmonary disease clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $857.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$38K
- Inari Medical, Inc.$14K
- Imperative Care, Inc$195
- United Therapeutics Corporation$143
- Aidoc Medical Ltd$114
- Intuitive Surgical$20
What the payments were for
- Consulting fees$34,45065%
- Speaking & faculty fees$8,30016%
- Travel & lodging$7,60514%
- Food & beverage$2,8175%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 28 | $38,299 |
| Inari Medical, Inc. | 30 | $14,402 |
| Imperative Care, Inc | 1 | $195 |
| United Therapeutics Corporation | 1 | $143 |
| Aidoc Medical Ltd | 1 | $114 |
| Intuitive Surgical | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$51,312
- FLOWTRIEVER CATHETER, S$50,994
- CLOTTRIEVER BOLD CATHETER$728
- SYMPHONY CATHETER$195
- FlowTriever$136
- Briefcase$114
How this compares
$53,172 in reported general payments places this provider in the 90th percentile of 1,261 pulmonary disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spiriva HandihalerTiotropium Bromide | 13 | $7,060 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $810 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Moreno Valley
- Samuel LouieSacramento$2.8M
- Shyamsunder SubramanianTracy$1.5M
- Toby MaherLos Angeles$1.3M
- Rajkumar DasguptaPasadena$930K
- Hoang leFountain Valley$814K
- Kevin FussellEncinitas$788K
- Revati ShreeniwasStanford$726K
- David PhamWestminster$571K
- Vijay BalasubramanianFresno$529K
- Victor TapsonLos Angeles$514K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.